TMED3 enhances breast cancer cell proliferation by stimulating the Wnt/β-catenin cascade, which causes an increased expression of relevant cell cycle proteins, including CDK4, c-myc and cyclinD1 [55]. This evidence concerns the gene TMED3 and breast carcinoma.